Chemoproteomics-based target profiling of sinomenine reveals multiple protein regulators of inflammation†
Abstract
Although sinomenine (SIN) has been used to treat several inflammation-related diseases in the clinic for decades, the detailed anti-inflammatory mechanism remains elusive. Here, we present a chemoproteomic study that supports a polypharmacological mode of action for SIN to inhibit inflammation. Notably, functional validation revealed multiple new protein regulators whose knockdown could significantly affect inflammation.
 
                




 Please wait while we load your content...
                                            Please wait while we load your content...
                                        